Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Agios Pharmaceuticals Inc

+ Add to Watchlist

8AP:GR

85.951 EUR 4.939 6.10%

As of 13:28:16 ET on 05/04/2015.

Snapshot for Agios Pharmaceuticals Inc (8AP)

Open: 83.685 Day's Range: 83.685 - 85.951 Volume: 0
Previous Close: 81.012 52wk Range: 22.789 - 117.804 1-Yr Rtn: +181.11%

Stock Chart for 8AP

No chart data available.
  • 8AP:GR 83.821
  • 1D
  • 1M
  • 1Y
81.012
Interactive 8AP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8AP

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -2.9960
Est. PEG Ratio -
Market Cap (M EUR) 3,205.03
Shares Outstanding (M) 37.29
30 Day Average Volume 429
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8AP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 8AP

Agios Pharmaceuticals, Inc. discovers and develops therapeutics in the field of cancer metabolism. The Company develops drugs focusing on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals operates in the United States.

David P SchenkeinChief Executive OfficerJ Duncan HiggonsChief Operating Officer
Chris BowdenChief Medical OfficerScott BillerChief Scientific Officer
More Company Profile & Key Executives for 8AP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil